Safety Study of CADI-05 in Patients With Advanced Stage Melanoma

Clinical trial NCT00675727 · TERMINATED

Trial details

NCT number: NCT00675727
Sponsor: Cadila Pharnmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage III or Stage IV Melanoma

Start date: 2006-12-01
Primary completion: 2010-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.